medRxivGenetic & Genomic MedicinePreprint
Expanding the phenotypic spectrum of TRAF7 syndrome: report of eleven new cases and literature review.
Carmen Palma MillaiD, Aina Prat-PlanasiD, Emma Soengas‐GondaiD, Mónica Centeno-PlaiD, Jaime Sánchez-Pozo, Irene RodrígueziD, Juan Francisco Quesada‐EspinosaiD, Ana Arteche‐LópeziD, Jonathan OlivaliD, Marta Pacio MigueziD, María Palomares‐BraloiD, Fernando Santos‐SimarroiD, Ramón Cancho CandelaiD, María Vázquez LópeziD, Verónica Seidel, Antonio Federico Martínez‐MonsenyiD, Dídac Casas‐AlbaiD, Daniel GrinbergiD, Susana BalcellsiD, Mercedes SerranoiD, Raquel RabionetiD, Miguel Angel MartíniD, Roser UrreiztiiD
Abstract
TRAF7 syndrome, a multisystemic neurodevelopmental disorder caused by germline missense variants in the TRAF7 gene, exhibits heterogeneous clinical presentations. We present a detailed description of eleven new TRAF7 syndrome cases, featuring eight distinct variants, including a novel one. Phenotypic analysis and a comprehensive review of the 58 previously reported cases outline consistent clinical presentations, emphasizing dysmorphic features, developmental delay, endocrine manifestations, and cardiac defects. In this enlarged collection, novelties include a wider range of cognitive dysfunction, with some individuals exhibiting normal development despite early psychomotor delay. Communication challenges, particularly in expressive language, are prevalent, necessitating alternative communication methods. Autistic traits, notably rigidity, are observed in the cohort. Also, worth highlighting are hearing loss, sleep disturbances, and endocrine anomalies, including growth deficiency. Cardiac defects, frequently severe, pose early-life complications. Facial features, including arched eyebrows, contribute to the distinct gestalt. A novel missense variant, p.(Arg653Leu), further underscores the complex relationship between germline TRAF7 variants and somatic changes linked to meningiomas. Our comprehensive analysis expands the phenotypic spectrum, emphasizing the need for oncological evaluations and proposing an evidence-based schedule for clinical management. This study contributes to a better understanding of TRAF7 syndrome, offering insights for improved diagnosis, intervention, and patient care. Key MessageTRAF7 syndrome, a complex neurodevelopmental disorder, exhibits variable cognitive outcomes, complex behavioral presentation and clinical complications emphasizing the need for tailored interventions and follow-up.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Delineating the molecular and phenotypic spectrum of the SETD1B-related syndrome
Marjolein J.A. Weerts, Kristina Lanko, … Tahsin Stefan Barakat·Genetics in MedicinePeer-reviewed·Aug 3, 2021
- A variant in TAF1 is associated with a new syndrome with severe intellectual disability and characteristic dysmorphic features
Jason O'Rawe, Yiyang Wu, … Gholson Lyon·The American Journal of Human GeneticsPeer-reviewed·Dec 1, 2015
- KBG Syndrome: Prospective Videoconferencing and Use of AI-driven Facial Phenotyping in 25 New Patients
Lily Guo, Jiyeon Park, … Gholson J. Lyon·medRxiv·Nov 18, 2021
- Expanding clinical and variant spectrum of CBX1-related syndrome: Report of three novel cases
Graciela Carrollo, Shuhei Fujino, … Kosuke Izumi·medRxiv·Sep 28, 2026
- Clinical description, molecular delineation, and genotype-phenotype correlation in KBG syndrome: 67 new patients and review of the literature.
Elena Martínez‐Cayuelas, Fiona Blanco‐Kelly, … Berta Almoguera·Journal of Medical GeneticsPeer-reviewed·Nov 29, 2022
- BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations
Angela Peron, Felice D’Arco, … Cristina Dias·European Journal of Human GeneticsPeer-reviewed·Oct 24, 2024